Related references
Note: Only part of the references are listed.The M694V mutationinArmenian-Americans: a 10-year retrospective study of MEFV mutation testing for familial Mediterranean fever at UCLA
F. S. Ong et al.
CLINICAL GENETICS (2013)
Homozygous M694V as a risk factor for amyloidosis in Turkish FMF patients
Tekin Akpolat et al.
GENE (2012)
Familial Mediterranean Fever Risk Factors, Causes of Death, and Prognosis in the Colchicine Era
Servet Akar et al.
MEDICINE (2012)
The regulation of MEFV expression and its role in health and familial Mediterranean fever
S. Grandemange et al.
GENES AND IMMUNITY (2011)
Familial Mediterranean Fever in the World
Eldad Ben-Chetrit et al.
ARTHRITIS CARE & RESEARCH (2009)
Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy
Jae J. Chae et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever
Isabelle Touitou et al.
ARTHRITIS AND RHEUMATISM (2007)
Familial Mediterranean fever (FMF) in Turkey - Results of a nationwide multicenter study
M Tunca et al.
MEDICINE (2005)
The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever
R Gershoni-Baruch et al.
ARTHRITIS AND RHEUMATISM (2003)
Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosis
F Yalcinkaya et al.
RHEUMATOLOGY (2000)
Share Paper
